輔酶 Q10 (輔酵素 Q10) Coenzyme Q10 × 男性不孕症

結論:證據支持但有警示

證據呈現典型「替代終點 vs 患者終點」分裂:精液參數(surrogate)一致改善(L1 Examine Seminal Motility B、Sperm Count D;L2 PMID 40878114/39830337 SMD 7.

B 🟡 B 初步證據 附警語發布 low — community discussion mostly non-commercial
⚠️ 標記 🧪 反證據已標記 🇹🇼 台灣在地警示 💊 檢驗 / 藥物交互作用

證據呈現典型「替代終點 vs 患者終點」分裂:精液參數(surrogate)一致改善(L1 Examine Seminal Motility B、Sperm Count D;L2 PMID 40878114/39830337 SMD 7.26 motility、testosterone SMD 0.59 皆顯著),但臨床懷孕率/活產率(patient-relevant primary endpoint)證據薄弱且不穩定 — Cochrane 2022 (PMID 35506389) 整體抗氧化劑活產 OR 1.43 (95% CI 1.07-1.91) 在排除高偏差研究後變為 OR 1.22 (95% CI 0.85-1.75) 不顯著、GRADE 評為 very low-certainty;2025 CoQ10-specific MA 雖報 OR 6.02 但僅 9 篇小型 RCT、信賴區間 1.97-18.41 極寬,極可能 publication bias。

NIH/NCCIH 直接陳述「research is too limited for any conclusions」、ASRM/AUA Guideline Statement 45 明確以「questionable clinical utility」否定例行使用、Cleveland Clinic 限縮在 MOSI 亞組才推薦、Mayo cautious_supportive、Harvard 無 consumer-facing 文章。

L1 Examine 給最佳 grade B 來自 motility(一個 surrogate),但同表 Sperm Count D、Sperm Quality 在 Infertility 條目下亦為 D,且最重要的活產/懷孕未列。

因此給 C(薄弱證據,僅亞組精液參數有實證、患者終點不確定)比 B(中度證據)更貼近實況,且與 ASRM/AUA + NIH + Cleveland (條件性) 三方共識一致。

⚖️

評分透明度

所有分數由 7 層證據引擎計算,過程公開可查
原始分數 0.63
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
B · 附警語發布
信心度
81%
證據方向一致性高
證據層級
E1
Cochrane 高品質系統性回顧/統合分析

各層「支持此療效」的程度

分數越低=該層越不支持
L5 臨床機構權威立場
0.47
L1 Examine國際基準
0.50
L11 AI 複核獨立判讀
0.50
L2 PubMed原始文獻
0.75
L3 機轉生理合理性
0.75
不支持 中性 / 混合 支持
查看完整決策路徑(audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.629
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (3 篇 > 0 negative)
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

Antioxidants for male subfertility (Cochrane Review, pub5 update)
PMID: 35506389 2022 Cochrane SR n = 10,303
結論:Antioxidants may increase live birth (12 RCTs, n=1283: OR 1.43, 95% CI 1.07-1.91; baseline 16% → 17-27%) and clinical pregnancy (20 RCTs, n=1706: OR 1.89, 95% CI 1.45-2.47, p<0.00001). However, when high-risk-of-bias studies were removed, live-birth effect lost significance (OR 1.22, 95% CI 0.85-1.75, p=0.27). GRADE: very low-certainty for live birth, low-certainty for pregnancy. Mild GI side effects more common (OR 2.70, 95% CI 1.46-4.99).
🟢 高品質 學術資助 效應量:[object Object]
前往 PubMed
Efficacy and Safety of Coenzyme Q10 in Idiopathic Male Infertility: A Systematic Review and Meta-Analysis of Randomized Trials
PMID: 40878114 2025 統合分析 n = 781
結論:CoQ10 significantly improved sperm concentration (MD +10.22 ×10⁶/mL, 95% CI 3.51-16.93, p=0.003), total motility (MD +4.95%, 95% CI 1.15-8.75, p=0.01), seminal volume (MD +0.17 mL, 95% CI 0.03-0.31, p=0.02), seminal CoQ10 levels, and clinical pregnancy odds (OR 6.02, 95% CI 1.97-18.41, p=0.002). Morphology improved with >3-month treatment. Live birth not pooled. Generally safe (3 of 4 studies reporting AEs found none; 1 mild transient).
效應量:[object Object]
前往 PubMed
Does coenzyme Q10 improve semen quality and circulating testosterone level? a systematic review and meta-analysis of randomized controlled trials
PMID: 39830337 2025 統合分析 n = 877
結論:Significant improvements in total sperm count (SMD 13.38, 95% CI 10.43-16.33, p<0.0001), total motility (SMD 7.26, 95% CI 4.36-10.15, p<0.00001), progressive motility (SMD 6.39, 95% CI 2.73-10.04, p=0.0006), normal morphology (SMD 1.96, 95% CI 0.62-3.29, p=0.004); serum testosterone increased (SMD 0.59, p<0.00001), inhibin B increased, LH/FSH decreased. No significant change in semen volume or sperm concentration in this pooled subset. Pregnancy/live birth NOT reported.
學術資助 效應量:[object Object]
前往 PubMed
Coenzyme Q10 and Male Infertility: A Systematic Review
PMID: 34070761 2021 系統性回顧
結論:CoQ10 monotherapy improved sperm motility in nearly all included studies; sperm concentration improved in several; morphology gains less consistent. Pregnancy data sparse: one study reported 23.8% pregnancy in CoQ10 vs 4.9% placebo; another 34.1% over ~8.4 months. 200-400 mg/day for >3 months shows the most consistent semen-parameter benefit; ubiquinol 400 mg > 200 mg in head-to-head dose comparison. No CI provided in narrative tables.
學術資助 效應量:[object Object]
前往 PubMed
Coenzyme Q10 improves sperm motility and antioxidant status in infertile men with idiopathic oligoasthenospermia
PMID: 36482502 2022 RCT (open-label) n = 85
結論:Progressive motility improved (p<0.05) and total motility increased (p<0.01) after 12 weeks. Sperm concentration showed no significant improvement; morphology slightly decreased non-significantly. Seminal antioxidants (TAC, SOD, GPx) increased; ROS decreased; seminal CoQ10 rose markedly (p<0.001). Sperm parameters correlated with antioxidant indices (r 0.38-0.57). Pregnancy/live birth NOT primary endpoints.
🟠 品質有限 學術資助
前往 PubMed

L4a US FDA
謹慎
not generally recognized as safe and effective for the referenced uses and therefore are considered "new drugs" 來源↗
L4b EU EFSA
反對
a cause and effect relationship has not been established between the consumption of coenzyme Q10 and the claimed effects 來源↗
L4c UK NHS
謹慎
Advise people with migraine that the food supplement riboflavin (400 mg once a day) may be effective in reducing migraine frequency and intensity for some people. 來源↗
L4d TW TFDA / 衛福部
謹慎
訂定「食品原料輔酵素Q10 (Coenzyme Q10)之使用限制及標示規定」 來源↗
L4e WHO
未表態
— 本適應症無對應資料

L5a NIH Office of Dietary Supplements
謹慎
— 本適應症無對應資料
L5b Mayo Clinic
謹慎
may improve sperm motility 來源↗
L5c Cleveland Clinic
中性
Male oxidative stress infertility (MOSI) is really the only condition that can be treated effectively with male fertility supplements. 來源↗
L5d Harvard Health
中性
— 本適應症無對應資料
L5e Specialty Society (condition-mapped)
謹慎
Clinicians should counsel patients that the benefits of supplements (e.g., antioxidants, vitamins) are of questionable clinical utility in treating male infertility. 來源↗

PTT · Dcard · Mobile01 彙整自公開論壇討論,非統計抽樣,僅反映社群風向。
廣告 / 業配密度 低度
📍立場總覽

台灣社群討論集中在 PTT 備孕版(GoodPregnan),Q10 壓倒性以女性養卵為主軸,男性精子品質屬少數附帶討論。鄉民多採夫妻同補策略,劑量參考國外養卵聖經(200-600mg),普遍對台灣 30mg 上限不以為然。整體經驗偏正面但夾雜大量女性用途,男性精子改善多為轉述醫囑或研究,非個人實測,業配密度低。

💬社群實感

分歧(女性養卵討論多且偏正面;男性精子品質討論稀少,多為轉述醫囑或研究而非個人實測,缺乏明確共識)

破解迷思 社群最常見的 4 個誤解
事實誤把女性養卵的高劑量(600mg)直接套用到男性精子,未區分用途與劑量
事實認為台灣藥局 30mg 規格『沒效』,一定要吃到國外 200mg 以上才有用(30mg 為健康維持量,並非備孕無效鐵證)
事實把『還原型一定優於氧化型』當成鐵律(生物利用率較高屬實,但精子品質臨床數據仍以一般 CoQ10 居多)
事實認為 Q10 能直接『治療』男性不孕,忽略其僅針對氧化壓力相關精蟲品質、且須 3-6 個月以上才見變化
🩹 社群通報的副作用
  • 高劑量(400mg 以上)腹瀉
  • 部分品牌空腹服用胃痛 / 腸胃不適
🏷️ 社群熱議品牌

依論壇被提及頻率,非銷售或品質排序。

  • Jarrow(還原型 Ubiquinol,鄉民常推)
  • Doctor's Best(Kaneka 泛醇)
  • 萊萃美 21st Century
  • DHC(日版 90mg)
  • iHerb 代購為主要購買管道

⚠️ 列出僅代表「TW 社群討論度高」,不代表本站推薦或背書。本站不販售任何產品、無導購連結。

查看代表討論串 ↗

L10a · 廠商行銷話術 行銷語言
💬 通路如何宣傳

保健食品食用純化的Q10限制為每日30毫克

代表來源 ↗
L10b · TFDA 法定身份 官方認定

每日食用限量為三十毫克

來源 ↗

  • 顯微精索靜脈曲張手術
  • 輔助生殖技術(IUI/IVF/ICSI)
  • 生活型態與危險因子調整
PMID 100% 反查全部經 NCBI Entrez 驗證
🔬 5 篇 L2 文獻 經多層 sub-agent 獨立評估
🇹🇼 含台灣社群分析L10c PTT / Dcard / Mobile01
aggregated_at: 2026-06-01 claim_version: v35 engine_version: v1.0 claim_id: CLM-COND-male-infertility-INT-coenzyme-q10-001
查看 ClaimReview 結構化資料 (JSON-LD)
{
  "@context": "https://schema.org",
  "@type": "ClaimReview",
  "url": "https://gpt-dict.com/claim/CLM-COND-male-infertility-INT-coenzyme-q10-001/",
  "datePublished": "2026-06-01",
  "author": {
    "@type": "Organization",
    "name": "gpt-dict.com",
    "url": "https://gpt-dict.com"
  },
  "claimReviewed": "輔酶 Q10 (輔酵素 Q10)能改善男性不孕症",
  "inLanguage": "zh-TW",
  "itemReviewed": {
    "@type": "Claim",
    "appearance": []
  },
  "reviewRating": {
    "@type": "Rating",
    "ratingValue": 3,
    "bestRating": 5,
    "worstRating": 1,
    "alternateName": "🟡 B 初步證據"
  }
}